Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib
NCT00782834Phase 2Terminated
- Sponsor
- Fox Chase Cancer Center
- Start
- Jul 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in gastrointestinal stromal tumor (GIST), sponsored by Fox Chase Cancer Center. Started Jul 2008; status: terminated.
02
Drugs
nilotinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00782834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782834.